GH Research GHRS
NASDAQ GHRS
$19.25 -0.31 (-1.59%)
As of: Nov 11, 2026 · 12:27 PM EST

GH Research (GHRS) Net Equity Issued and Repurchased (2025 - 2026)

Updated

GH Research's Net Equity Issued and Repurchased was $117.97 million in Q2 2026.

Analysis

GH Research (GHRS) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, GH Research's Net Equity Issued and Repurchased was -$31.96 million through Jun 30, 2026; for FY2023, it came in at $15,000.

  • Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -63.0% (FY2019 to FY2023).
  • In earlier years, Net Equity Issued and Repurchased was $309.2 million in FY2021, $5.5 million in FY2020 (+590.1%) and $797,000 in FY2019.
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 GH Research 1.21 Bn 87.22 Mn - 117.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.97 Mn
Mar 31, 2026 72,000.00
Dec 31, 2025 -150.00 Mn
Mar 31, 2025 150.00 Mn
API Access

GH Research Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GHRS&period=max&api_key=YOUR_API_KEY